← Back to front page
Europe · Wires & real time · AFP Économie

Ropeg obtient les autorisations de mise sur le marché dans les principaux marchés mondiaux, tandis que les patients européens attendent toujours de pouvoir bénéficier de ...

Published by AFP Économie · France 1 d ago

Le traitement de PharmaEssentia destiné aux cancers du sang, le ropeginterféron alfa-2b (Ropeg), a obtenu des autorisations de mise sur le marché pour la thrombocytémie…

Read the full article on AFP Économie Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.afp.com)

Also worth reading

TASS

Russia poses no threat to anyone and seeks cooperation — Putin

 Anadolu Agency

UAE mulls 3rd oil pipeline to bypass Strait of Hormuz: Report

 Reuters US Markets

Prediction markets get Democratic win right, with a few surprises

 Reuters

Meta draws record orders for debut euro bond sale, Bloomberg News reports

 Reuters Business

US trade deficit narrows slightly in September; imports hit record high

 Reuters Technology

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026